Abstract
In this issue of Blood, Beygi et al(1) expanded our understanding of resistance to mogamulizumab in cutaneous T-cell lymphoma (CTCL) from loss or decr......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
